|
|
|
Volumn 17, Issue 1, 2012, Pages
|
|
11. The 2012 SEMDSA treatment algorithm for type 2 diabetes
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ACARBOSE;
EXENDIN 4;
GLIBENCLAMIDE;
GLICLAZIDE;
GLIMEPIRIDE;
GLIPIZIDE;
GLUCOSE;
GLYCOSYLATED HEMOGLOBIN;
HUMALOG MIX50;
INCRETIN;
INSULIN;
INSULIN ASPART;
INSULIN DETEMIR;
INSULIN GLARGINE;
INSULIN GLULISINE;
INSULIN LISPRO;
ISOPHANE INSULIN;
LINAGLIPTIN;
LIRAGLUTIDE;
METFORMIN;
NATEGLINIDE;
NEUTRAL INSULIN;
PIOGLITAZONE;
RECOMBINANT HUMAN INSULIN;
REPAGLINIDE;
ROSIGLITAZONE;
SAXAGLIPTIN;
SITAGLIPTIN;
SULFONYLUREA;
UNCLASSIFIED DRUG;
VILDAGLIPTIN;
DIAMICRON MR;
HUMAN INSULIN;
ABDOMINAL CRAMP;
ACUTE PANCREATITIS;
ANGIONEUROTIC EDEMA;
BLADDER DISEASE;
BLADDER TOXICITY;
BLUNT MYOCARDIAL ISCHEMIA;
C CELL HYPERPLASIA;
CARDIOVASCULAR RISK;
CYANOCOBALAMIN DEFICIENCY;
DIARRHEA;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG RECALL;
DRUG SAFETY;
DRUG TOLERABILITY;
EDEMA;
FLATULENCE;
GLYCEMIC CONTROL;
HEART MUSCLE ISCHEMIA;
HUMAN;
HYPERPLASIA;
HYPOGLYCEMIA;
INSULIN TREATMENT;
KIDNEY DYSFUNCTION;
LACTIC ACIDOSIS;
MEDULLARY THYROID TUMOR;
MORTALITY;
NAUSEA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
OUTCOME ASSESSMENT;
PANCREATITIS;
SHORT SURVEY;
SIDE EFFECT;
THYROID TUMOR;
URTICARIA;
VOMITING;
WEIGHT GAIN;
ALGORITHM;
BLOOD GLUCOSE MONITORING;
CALORIC RESTRICTION;
CELL HYPERPLASIA;
CLINICAL TRIAL (TOPIC);
CONTROLLED CLINICAL TRIAL (TOPIC);
DIABETIC PATIENT;
DRUG CONTRAINDICATION;
DRUG TARGETING;
DRUG WITHDRAWAL;
GASTROINTESTINAL SYMPTOM;
HEMOGLOBIN BLOOD LEVEL;
INSULIN HYPOGLYCEMIA;
INSULIN RESISTANCE;
LIFESTYLE MODIFICATION;
MEDICAL SOCIETY;
MONOTHERAPY;
MUSCLE CRAMP;
PRACTICE GUIDELINE;
PRIMARY MEDICAL CARE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
URINARY TRACT;
|
|
EID: 84864808726
PISSN: 16089677
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (5)
|
|
References (0)
|
